AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05835544 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental: HIIT + BFR between cycling sets
Description: Complete 3 sets of five repetitions of 30 seconds cycling at 100% of maximal aerobic power with 30 seconds of active unloaded recovery between repetitions; 3 minutes of passive rest between sets. Blood flow restriction is applied for 2 minutes during the passive rest at 80% of limb occlusion pressure.
Study NCT05835544 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental: HIIT + BFR moderate occlusion during cycling
Description: Complete 3 sets of five repetitions of 30 seconds cycling at 70% of maximal aerobic power with 30 seconds of active unloaded recovery between repetitions; 3 minutes of passive rest between sets. Blood flow restriction is applied during and between exercise repetitions at 50% of limb occlusion pressure and deflated during passive rest periods.
Study NCT05372848 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Manual toothbrush
Description: volunteers who used manual toothbrush for at least 2 years
Study NCT05372848 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Electric toothbrush
Description: volunteers who used electric toothbrush for at least 2 years
Study NCT06445140 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Collecting the variables and Implementation of a behavioural intervention
Description: The observational phase (during 15 days)~* Two measurements per day for motivational variables and physical activity and nutrition~* Two measurements per day for nutrition~* Three measurements per day for fatigue~* Continuous PA measurement by accelerometer~The interventional phase :~Part A (during 7 days)~* measuring physical activity (PA)~* complete questionnaires and numerical scales :~  * Motivational factors~ * Self-evaluation of nutrition~ * Self-assessment of fatigue~Part B: BEHAVIORAL INTERVENTION (10 weeks),the APA teacher will call a patient once a week for follow-up.~Answer questionnaires and scales on the digital platform will be done :~* Motivational factors~* Self-evaluation of nutrition~* Self-assessment of fatigue~Part C : End of interventional phase(during 7 days)~* measuring physical activity~* complete questionnaires and numerical scales :~  * Motivational factors~ * Self-evaluation of nutrition~ * Self-assessment of fatigue
Study NCT05245708 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Description: Each subject will be assigned to intranasal administration of oxytocin (24 IU).
Study NCT05245708 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: intranasal placebo
Description: Each subject will be assigned to intranasal placebo.
Study NCT04918719 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetylcysteine
Description: The dosing of Acetylcysteine will be similar to the standard intravenous acetaminophen toxicity dosing: 150mg/kg in 200 milliliters of 5% Dextrose (D5W) infused over 1 hour, immediately followed by 50mg/kg in 500mL D5W infused over 4 hours, then 100mg/kg in 1000 milliliters D5W infused over 16 hours. (Any patient receiving t-PA who enrolls in the study will have their study drug infusion delayed by 24 hours after the completion of the t-PA infusion. )
Study NCT04918719 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Dextrose in Water
Description: The placebo will consist of a 5% Dextrose in Water instead of NAC (dosage and timigs are the same as the NAC arm). (Any patient receiving t-PA who enrolls in the study will have their study drug infusion delayed by 24 hours after the completion of the t-PA infusion. )
Study NCT06306937 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Evalution of serum levels of vitamin D and IL8
Description: Group 1 (Periodontitis Group): The intervention involves observing and analyzing individuals diagnosed with periodontitis based on established clinical criteria. The focus is on assessing vitamin D and IL8 levels in the serum and correlating these levels with the severity of periodontitis, determined by clinical indices such as probing depth, clinical attachment loss, and bleeding on probing.~Group 2 (Control Group): The intervention involves observing and analyzing individuals without any signs or history of periodontal disease. The focus is on assessing vitamin D and IL8 levels in the serum for comparison with the periodontitis group. This group serves as the healthy control for the study.
Study NCT05766202 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: An group intervention for multiparas with fear of childbirth
Description: The intervention consists of 4 group meetings, three during pregnancy and once after giving birth. It also includes a phone call.
Study NCT05835544 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental: HIIT + BFR high occlusion during cycling
Description: Complete 3 sets of five repetitions of 30 seconds cycling at 70% of maximal aerobic power with 30 seconds of active unloaded recovery between repetitions; 3 minutes of passive rest between sets. Blood flow restriction is applied during and between exercise repetitions at 80% of limb occlusion pressure and deflated during passive rest periods.
Study NCT05168189 — intervention group
Intervention type: DRUG
Intervention: Ivabradine
Description: follow up chronic coronary syndrome patients receiving Ivabradine for ( 6 months ) if the participants develop atrial fibrillation using 24 hours holter .
Study NCT05168189 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: transthoracic echo
Description: performing baseline transthoracic echo for all patients to exclude any chamber dilatation
Study NCT05168189 — intervention group
Intervention type: DEVICE
Intervention: 24 hours holter
Description: perform 24 hours Holter monitoring for all patients at the start of the study and follow up after 6 months
Study NCT04851522 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Di-Dak-Sol
Description: Topical solution applied externally.
Study NCT04851522 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: White Petrolatum
Description: Topical ointment applied externally
Study NCT05246826 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical Pilates Exercises
Description: Pilates exercises; warm-up and cool-down exercises will be performed for 5 repetitions, while other exercises will be performed by the same physiotherapist as 10 repetitions depending on the patient's pain and fatigue. The exercises will be advanced at the end of the 3rd week.
Study NCT05246826 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical Pilates Exercises and Conventional Treatment
Description: In addition to pilates exercises, a conventional treatment program will be applied. As part of the conventional treatment program, 20 minutes of Hotpack to the cervical area, 20 minutes of conventional Transcutaneous Electrical Nerve Stimulation (TENS) to the painful area (80 Hertz (Hz), 100 microseconds (μs), until tingling is felt, asymmetrical biphasic rectangular waveform), 8 minutes to the cervical area Ultrasound (US) (4 minutes + 4 minutes, 1.5 watts/cm2, 1 MHz, continuous) will be applied.
Study NCT05593276 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Empower@Home
Description: Participants will be provided with access to a 9-session online program and will receive supportive remote assistance throughout regarding technical and programmatic issues.
Study NCT05389501 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Social policy intervention to support women of reproductive years
Description: The project team will attempt to address this challenge by delivering the following interventions through social workers in underdeveloped primary healthcare settings to promote maternal and child health:~1. Developing a database on a digital app of participants in the study and use the data for development of an Index for Maternal Health and Wellbeing~2. Conducting a Community Assessment Needs~3. Conduct a psychosocial needs assessment~4. Develop interprofessional health workforce collaboration~5. Measure basic clinical health indicators~6. Provide health awareness and literacy training to participants
Study NCT05389501 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social policy intervention to support women of reproductive years
Description: The project team will attempt to address this challenge by delivering the following interventions through social workers in underdeveloped primary healthcare settings to promote maternal and child health:~1. Developing a database on a digital app of participants in the study and use the data for development of an Index for Maternal Health and Wellbeing~2. Conducting a Community Assessment Needs~3. Conduct a psychosocial needs assessment~4. Develop interprofessional health workforce collaboration~5. Measure basic clinical health indicators~6. Provide health awareness and literacy training to participants
Study NCT04809623 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Edecesertib
Description: Tablets administered orally
Study NCT04809623 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo to match edecesertib tablets administered orally
Study NCT04809623 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Standard of Care
Description: Immunosuppressive/immunomodulatory agents including but not limited to antimalarials (i.e. hydroxychloroquine), methotrexate, azathioprine and corticosteroids (i.e. prednisone)
Study NCT06360510 — intervention group
Intervention type: PROCEDURE
Intervention: %5 dextrose injection
Description: hydrodissection with %5 dextrose
Study NCT06360510 — intervention group
Intervention type: PROCEDURE
Intervention: betamethasone injection
Description: perineural betamethasone injection
Study NCT06435455 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GH21
Description: GH21 Capsules, Oral Drug Specification: 3mg/capsule; 10mg/capsule
Study NCT06435455 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D-1553
Description: D-1553 Film-coated Tablets, Oral Drug Sepcification: 200mg/tablet
Study NCT05903885 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: On-site Fecal Immunochemical Test (FIT) Kit Distribution
Description: Participants will receive home based Fecal Immunochemical Test (FIT) kit directly at the DMV site by the research staff.
Study NCT05903885 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Onsite with social media advertising Fecal Immunochemical Test (FIT) Kit Distribution
Description: Participants will receive home-based Fecal Immunochemical Test (FIT) kits directly at the DMV location through face-to-face contact, supplemented by exposure to targeted social media advertisements.
Study NCT06260137 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Rhomboid intercostal block
Description: Patients will be injected with a local anesthetic drug under the rhomboid intercostal muscle before surgery.
Study NCT06260137 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Rhomboid intercostal and subserratus plane block
Description: Patients will be injected with a local anesthetic drug under the rhomboid intercostal muscle and the serrates anterior muscle before surgery.
Study NCT06254664 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tiotropium 18 µg inhalation powder, hard capsule
Description: Tiotropium 18 µg administered using Zephir inhaler
Study NCT06254664 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Zephir inhaler
Description: Tiotropium 18 µg administered using Zephir inhaler
Study NCT04451369 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prehabilitation program
Description: physical, nutritional and psycho-social supports before surgery
Study NCT05780164 — intervention group
Intervention type: OTHER
Intervention: Research readiness tool
Description: Online/paper based tool containing information about lung cancer clinical trials
Study NCT06521437 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TMS targeting the hippocampus indirectly via its network
Description: Subjects will receive high-frequency repetitive TMS to a parieto-occipital location defined in each subject based on high resting-state fMRI connectivity with the hippocampus at baseline
Study NCT05970094 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low PRAL
Description: Two weeks on a low PRAL diet compared to 2 week free living
Study NCT06226168 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise and environmental conditions
Description: Participants will perform endurance-strength training for 4 weeks in a variety of environmental conditions. Somatic indices and quantitative indicators of bone mass (bone mineral density) will be measured both before and after the training period. Before the first training day and the day after the last training day, blood will be drawn for biochemical analysis.
Study NCT06226168 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise and environmental conditions
Description: Passive exposure to normobaric hypoxia conditions. No training intervention. There will be a measurement of selected somatic indices and a quantitative measurement of bone mass indices (bone mineral density). A blood draw for biochemical analysis will be performed.
Study NCT04695028 — intervention group
Intervention type: OTHER
Intervention: Data collection
Description: The following data will be collected by the physician: sociodemographic profile, clinical manifestations, comorbidities, laboratory tests,etc.~Diagnostic performance of different imagery techniques, performance of crystal deposit quantification in ultrasound and Dual-energy computed tomography (DECT), link between co-morbidities and volume of baseline crystal deposits then during monitoring, link between co-morbidities (including cardiovascular events and new diagnoses of co-morbidity) and vascular baseline crystal deposits and during follow-up, link between microcrystalline rheumatism activity and the quantity of crystal deposits in baseline imaging and during follow-up, link between co-morbidities and the evolution of microcrystalline baseline rheumatism and then during follow-up, link between co-morbidities and the evolution of crystal deposition volumes, the concordance of the evaluation of uratic stocks and their evolution between the imagery means.
Study NCT02223416 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RGB-10
Study NCT02223416 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Teriparatide
Study NCT06283732 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Greens powder
Description: Participants are to consume one scoop (8.5 g) of the greens powder mixed in 8-10 oz of water every morning before breakfast for two weeks.
Study NCT06206798 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resourcefulness Group
Description: The content of the Resourcefulness intervention group includes 6 sessions such as session 1 to introduce resourcefulness skills; sessions 2-4 to discuss personal resourcefulness skills including planning daily activities, and positive self-talk; sessions 4-5 to discuss social resourcefulness skills including relying on family or friends, and seeking professional assistance.
Study NCT06550427 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: ctDNA analyzed by phased variant
Description: this observational cohort study is to investigate the correlation between ctDNA analyzed by phased variant and the early outcome of the disease.
Study NCT03926520 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electroconvulsive Therapy (ECT)
Description: Stimulus method of delivery will be RUL electrode placement, and ultra-brief (UB) pulse width (0.25-0.37ms). At the first ECT session, seizure threshold (ST) will be determined by titration with the empirical dose titration method and subsequent treatments will be approximately 6 times the ST. Following other NIMH sponsored multicenter ECT studies (PRIDE, U01 MH055495), stimulus settings will be adjusted as needed during the ECT course based on seizure quality and treatment efficacy. Participants will be administered anesthesia.
Study NCT06373783 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: subepithelial connective tissue graft
Description: The area where the gingival recession occurred was prepared with the modified coronally positioned flap technique developed by Zuchelli. The subepithelial connective tissue graft was obtained in each patient using the single incision technique from the region between the mesial of the canine and the mesial of the first molar in the palate. Connective tissue dimensions were approximately 10x5x2 mm. The graft thickness was measured with an endodontic spreader from 3 points (mesial, buccal, and distal) and an electronic caliper during surgery.
Study NCT06373783 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: de- epithelize gingival graft
Description: The area where the gingival recession occurred was prepared with the modified coronally positioned flap technique developed by Zuchelli. A shallow horizontal incision was made at ≈3 mm apical from the gingival margin of the maxillary molar teeth using a number 15 scalpel blade. Subsequently, a parallel horizontal incision, at ≈ 4 mm apical from the first horizontal incision, was traced in conjunction with two vertical releasing incisions to delineate a rectangular area. Then, the uppermost epithelial layer was scraped off using a size 11 scalpel tip. The connective tissue graft to be taken from the palate area was 10x5x2 mm in size, and the graft thickness was measured with an endodontic spreader from 3 points (mesial, buccal, and distal) and electronic caliper during surgery.
Study NCT06373783 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: ultrasonography
Description: Clinical parameter measurements (probing depth (PD), clinical attachment level (CAL), gingival recession depth and width, keratinized tissue width and height) were taken on the day of surgery, the 3rd days, the 14th days, the 1st month, the 3rd months and the 6th months.~Ultrasonography measurements A 6-18 MHz intraoral probe was used in intraoral USG examinations. Sterile gel was applied to the intraoral probe and covered with a stretch film. Then, it was placed directly on the mucosal surface of the receiver site in the buccal area. Mucosal thickness was evaluated using the B-mode of the device, and vascularization was evaluated using the color doppler and pulsed wave doppler modes of the device. The following equation is used and calculated by US unit pulsatility index (PI) = (Vmax-Vmin) (Vmean) (Vmax is peak systolic flow velocity. Vmin is diastolic flow velocity and Vmean is mean flow velocity.) The mean PI values of each patient were measured.
Study NCT05300841 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dydrogesterone 20 mg /d (Duphaston, Abott Healthcare , Egypt)
Description: Pretreatment with dydrogestrone (Duphaston, Abott Healthcare, Egypt) will be administered during the cycle preceding the ICSI cycle in a daily dose of 20 mg/ day starting 10 days before the presumed onset of menses
Study NCT05300841 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: estradiol valerate 2 mg /d (white tablets of cycloprognova, Bayer Shering, Germany)
Description: will receive dydrogestrone 10mg /day plus estradiol valerate 2 mg /d (white tablets of cycloprognova, Bayer Schering, Germany) for 10 days.
Study NCT05517902 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: StrataGraft
Description: StrataGraft® Construct
Study NCT05748366 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Serratus Anterior Plane Block (SAPB)
Description: The ultrasound-guided serratus anterior plane block (SAPB) will be performed in a manner previously described in published medical literature. Patients will be consented and monitored. Bupivacaine 0.5% (5 mg/ml) diluted to 30-40 ml will be used in a dose not to exceed 2 mg/kg. The serratus anterior fascial plane will be identified in the 4th/5th intercostal space. The needle will be advanced under real-time ultrasound guidance targeting the superficial serratus anterior fascial plane. The procedure assistant will inject small volumes to hydrodissect the muscle bellies evenly under direct visualization, indicating local anesthetic spread within the fascial plane. Anesthetic will then be injected in 5 ml increments and the needle will be removed. Patient will be continuously monitored on telemetry and pulse-oximetry. Reassessment of the patient will continue for 30 minutes to monitor for signs of local anesthetic systemic toxicity.
Study NCT05748366 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Standard Analgesic Medications
Description: Analgesic medications will be administered via the intravenous, intramuscular or oral route at the discretion of the medical treatment team.
Study NCT05748366 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard Analgesic Medications
Description: Analgesic medications will be administered via the intravenous, intramuscular or oral route at the discretion of the medical treatment team.
Study NCT06235827 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Green tean group
Description: Patients in Group A will have to consume two cups (250ml for each cup) of hot green tea, five days per week for 6 months. A tea bag is brewed in 250ml hot water for 3 minutes. They are only allowed to consume as hot drink, not for iced tea. Any sweetener or sugar is not allowed to mix in the drink. The green tea bag will be distributed to patient at beginning of research and at every visit. Patient will be reminded weekly using text messages or phone call by a research assistant for green tea consumption.
Study NCT06235827 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Control group
Description: Patients in Group B will not be consuming green tea during 6 months of study period.
Study NCT04723225 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cat-Cow Yoga
Description: Cat-Cow is one of the essential postures in yoga for its beneficial reasons. It is an alternate shift of posture from flexion of the back (rounded) to the extension of the back (arched). During each set of movement, inhalation and exhalation will be guided